Encapsulated therapeutic stem cells implanted in the tumor resection cavity induce cell death in gliomas

Nature Neuroscience

Volumn 15, Issue 2, 2012, Pages 197-204

  Kauer, Timo M ^a   Figueiredo, Jose Luiz ^a   Hingtgen, Shawn ^a   Shah, Khalid ^a,b  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

^b HARVARD STEM CELL INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CASPASE; TUMOR NECROSIS FACTOR RELATED APOPTOSIS INDUCING LIGAND;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CANCER SURGERY; CANCER SURVIVAL; CELL ENCAPSULATION; CELL MIGRATION; CONTROLLED STUDY; EXTRACELLULAR MATRIX; FEMALE; GLIOBLASTOMA; HUMAN; HUMAN CELL; IN VIVO STUDY; MOUSE; NONHUMAN; PRIORITY JOURNAL; STEM CELL TRANSPLANTATION; TUMOR CELL;

ANIMALS; BRAIN NEOPLASMS; CASPASE 3; CASPASE 7; CELL COUNT; CELL DEATH; CELL ENGINEERING; CELL LINE, TUMOR; CELL MOVEMENT; CELL PROLIFERATION; DISEASE MODELS, ANIMAL; GENE EXPRESSION REGULATION, NEOPLASTIC; GLIOBLASTOMA; HUMANS; LUMINESCENT PROTEINS; MICE; MICE, NUDE; STEM CELL TRANSPLANTATION; STEM CELLS; TIME FACTORS; TNF-RELATED APOPTOSIS-INDUCING LIGAND; TRANSFECTION; XENOGRAFT MODEL ANTITUMOR ASSAYS;

EID: 84856263167     PISSN: 10976256     EISSN: 15461726     Source Type: Journal    
DOI: 10.1038/nn.3019     Document Type: Article

References (50)

1. Adamson, C. et al. Glioblastoma multiforme: a review of where we have been and where we are going. Expert Opin. Investig. Drugs 18, 1061-1083 (2009).
2. Affronti, M.L. et al. Overall survival of newly diagnosed glioblastoma patients receiving carmustine wafers followed by radiation and concurrent temozolomide plus rotational multiagent chemotherapy. Cancer 115, 3501-3511 (2009).
3. Wen, P.Y. & Kesari, S. Malignant gliomas in adults. N. Engl. J. Med. 359, 492-507 (2008).
4. Asthagiri, A.R., Pouratian, N., Sherman, J., Ahmed, G. & Shaffrey, M.E. Advances in brain tumor surgery. Neurol. Clin. 25, 975-1003, viii-ix (2007). (Pubitemid 47600574)
5. Erpolat, O.P. et al. Outcome of newly diagnosed glioblastoma patients treated by radiotherapy plus concomitant and adjuvant temozolomide: a long-term analysis. Tumori 95, 191-197 (2009).
6. Minniti, G. et al. Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma in elderly patients. J. Neurooncol. 88, 97-103 (2008).
7. Muldoon, L.L. et al. Chemotherapy delivery issues in central nervous system malignancy: a reality check. J. Clin. Oncol. 25, 2295-2305 (2007). (Pubitemid 46954658)
8. Jain, R.K., Tong, R.T. & Munn, L.L. Effect of vascular normalization by antiangiogenic therapy on interstitial hypertension, peritumor edema, and lymphatic metastasis: insights from a mathematical model. Cancer Res. 67, 2729-2735 (2007). (Pubitemid 46548961)
9. Sarin, H. Recent progress towards development of effective systemic chemotherapy for the treatment of malignant brain tumors. J. Transl. Med. 7, 77 (2009).
10. Corsten, M.F. & Shah, K. Therapeutic stem-cells for cancer treatment: hopes and hurdles in tactical warfare. Lancet Oncol. 9, 376-384 (2008). (Pubitemid 351411654)
11. Balyasnikova, I.V., Ferguson, S.D., Han, Y., Liu, F. & Lesniak, M.S. Therapeutic effect of neural stem cells expressing TRAIL and bortezomib in mice with glioma xenografts. Cancer Lett. 310, 148-159 (2011).
12. Ehtesham, M. et al. Induction of glioblastoma apoptosis using neural stem cell-mediated delivery of tumor necrosis factor-related apoptosis-inducing ligand. Cancer Res. 62, 7170-7174 (2002). (Pubitemid 36025232)
13. Germano, I.M., Uzzaman, M., Benveniste, R.J., Zaurova, M. & Keller, G. Apoptosis in human glioblastoma cells produced using embryonic stem cell-derived astrocytes expressing tumor necrosis factor-related apoptosis-inducing ligand. J. Neurosurg. 105, 88-95 (2006). (Pubitemid 43979102)
14. Menon, L.G. et al. Human bone marrow-derived mesenchymal stromal cells expressing S-TRAIL as a cellular delivery vehicle for human glioma therapy. Stem Cells 27, 2320-2330 (2009).
15. Shah, K. Mesenchymal stem cells engineered for cancer therapy. Adv. Drug Deliv. Rev. doi:10.1016/j.addr.2011.06.010 (29 June 2011).
16. Pan, L., Ren, Y., Cui, F. & Xu, Q. Viability and differentiation of neural precursors on hyaluronic acid hydrogel scaffold. J. Neurosci. Res. 87, 3207-3220 (2009).
17. Park, K.I., Teng, Y.D. & Snyder, E.Y. The injured brain interacts reciprocally with neural stem cells supported by scaffolds to reconstitute lost tissue. Nat. Biotechnol. 20, 1111-1117 (2002). (Pubitemid 35285439)
18. Teng, Y.D. et al. Functional recovery following traumatic spinal cord injury mediated by a unique polymer scaffold seeded with neural stem cells. Proc. Natl. Acad. Sci. USA 99, 3024-3029 (2002). (Pubitemid 34240579)
19. Ma, W. et al. CNS stem and progenitor cell differentiation into functional neuronal circuits in three-dimensional collagen gels. Exp. Neurol. 190, 276-288 (2004). (Pubitemid 39504987)
20. Potter, W., Kalil, R.E. & Kao, W.J. Biomimetic material systems for neural progenitor cell-based therapy. Front. Biosci. 13, 806-821 (2008). (Pubitemid 351594730)
21. Hingtgen, S. et al. Targeting multiple pathways in gliomas with stem cell and viral delivered S-TRAIL and Temozolomide. Mol. Cancer Ther. 7, 3575-3585 (2008).
22. Shah, K. et al. Bimodal viral vectors and in vivo imaging reveal the fate of human neural stem cells in experimental glioma model. J. Neurosci. 28, 4406-4413 (2008).
23. Panner, A., James, C.D., Berger, M.S. & Pieper, R.O. mTOR controls FLIPS translation and TRAIL sensitivity in glioblastoma multiforme cells. Mol. Cell. Biol. 25, 8809-8823 (2005). (Pubitemid 41429073)
24. Rieger, J., Naumann, U., Glaser, T., Ashkenazi, A. & Weller, M. APO2 ligand: a novel lethal weapon against malignant glioma? FEBS Lett. 427, 124-128 (1998). (Pubitemid 28210109)
25. Akbar, U. et al. Delivery of temozolomide to the tumor bed via biodegradable gel matrices in a novel model of intracranial glioma with resection. J. Neurooncol. 94, 203-212 (2009).
26. de Oliveira, M.S. et al. Anti-proliferative effect of the gastrin-release peptide receptor antagonist RC-3095 plus temozolomide in experimental glioblastoma models. J. Neurooncol. 93, 191-201 (2009).
27. Orive, G., Anitua, E., Pedraz, J.L. & Emerich, D.F. Biomaterials for promoting brain protection, repair and regeneration. Nat. Rev. Neurosci. 10, 682-692 (2009).
28. Xu, X., Yang, G., Zhang, H. & Prestwich, G.D. Evaluating dual activity LPA receptor pan-antagonist/autotaxin inhibitors as anti-cancer agents in vivo using engineered human tumors. Prostaglandins Other Lipid Mediat. 89, 140-146 (2009).
29. Mooney, D.J. & Vandenburgh, H. Cell delivery mechanisms for tissue repair. Cell Stem Cell 2, 205-213 (2008). (Pubitemid 351298597)
30. Terrovitis, J. et al. Ectopic expression of the sodium-iodide symporter enables imaging of transplanted cardiac stem cells in vivo by single-photon emission computed tomography or positron emission tomography. J. Am. Coll. Cardiol. 52, 1652-1660 (2008).
31. Ashkenazi, A. & Dixit, V.M. Death receptors: signaling and modulation. Science 281, 1305-1308 (1998). (Pubitemid 28406815)
32. Sasportas, L.S. et al. Assessment of therapeutic efficacy and fate of engineered human mesenchymal stem cells for cancer therapy. Proc. Natl. Acad. Sci. USA 106, 4822-4827 (2009).
33. Hingtgen, S.D., Kasmieh, R., van de Water, J., Weissleder, R. & Shah, K. A novel molecule integrating therapeutic and diagnostic activities reveals multiple aspects of stem cell-based therapy. Stem Cells 28, 832-841 (2010).
34. Tian, X. et al. Modulation of chop-dependent DR5 expression by nelfinavir sensitizes glioblastoma multiforme cells to tumor necrosis factor-related apoptosis-inducing ligand (TRAIL). J. Biol. Chem. 286, 29408-29416 (2011).
35. Chen, J., Sun, X., Yang, W., Jiang, G. & Li, X. Cisplatin-enhanced sensitivity of glioblastoma multiforme U251 cells to adenovirus-delivered TRAIL in vitro. Tumour Biol. 31, 613-622 (2010).
36. Kahana, S. et al. Proteasome inhibitors sensitize glioma cells and glioma stem cells to TRAIL-induced apoptosis by PKCε-dependent downregulation of AKT and XIAP expressions. Cell. Signal. 23, 1348-1357 (2011).
37. Siegelin, M.D., Gaiser, T., Habel, A. & Siegelin, Y. Daidzein overcomes TRAIL-resistance in malignant glioma cells by modulating the expression of the intrinsic apoptotic inhibitor, bcl-2. Neurosci. Lett. 454, 223-228 (2009).
38. Kim, S.M. et al. Irradiation enhances the tumor tropism and therapeutic potential of tumor necrosis factor-related apoptosis-inducing ligand-secreting human umbilical cord blood-derived mesenchymal stem cells in glioma therapy. Stem Cells 28, 2217-2228 (2010).
39. van Eekelen, M. et al. Human stem cells expressing novel TSP-1 variant have anti-angiogenic effect on brain tumors. Oncogene 29, 3185-3195 (2010).
40. Ren, B. et al. A double hit to kill tumor and endothelial cells by TRAIL and antiangiogenic 3TSR. Cancer Res. 69, 3856-3865 (2009).
41. Kock, N., Kasmieh, R., Weissleder, R. & Shah, K. Tumor therapy mediated by lentiviral expression of shBcl-2 and S-TRAIL. Neoplasia 9, 435-442 (2007). (Pubitemid 46799987)
42. Pandita, A., Aldape, K.D., Zadeh, G., Guha, A. & James, C.D. Contrasting in vivo and in vitro fates of glioblastoma cell subpopulations with amplified EGFR. Genes Chromosom. Cancer 39, 29-36 (2004). (Pubitemid 37475250)
43. Wakimoto, H. et al. Human glioblastoma-derived cancer stem cells: establishment of invasive glioma models and treatment with oncolytic herpes simplex virus vectors. Cancer Res. 69, 3472-3481 (2009).
44. Bagci-Onder, T., Wakimoto, H., Anderegg, M., Cameron, C. & Shah, K. A dual PI3K/mTOR inhibitor, PI-103, cooperates with stem cell-delivered TRAIL in experimental glioma models. Cancer Res. 71, 154-163 (2011).
45. Snyder, E.Y. The risk of putting something where it does not belong: Mesenchymal stem cells produce masses in the brain. Exp. Neurol. 230, 75-77 (2011).
46. Hall, B. et al. Mesenchymal stem cells in cancer: tumor-associated fibroblasts and cell-based delivery vehicles. Int. J. Hematol. 86, 8-16 (2007). (Pubitemid 47204483)
47. Karnoub, A.E. et al. Mesenchymal stem cells within tumour stroma promote breast cancer metastasis. Nature 449, 557-563 (2007). (Pubitemid 47525152)
48. Grigoriadis, N. et al. Variable behavior and complications of autologous bone marrow mesenchymal stem cells transplanted in experimental autoimmune encephalomyelitis. Exp. Neurol. 230, 78-89 (2011).
49. Choi, S.A. et al. Human adipose tissue-derived mesenchymal stem cells: characteristics and therapeutic potential as cellular vehicles for prodrug gene therapy against brainstem gliomas. Eur. J. Cancer published online, doi:10.1016/j.ejca.2011.04.033 (8 June 2011).
50. Mattis, V.B. & Svendsen, C.N. Induced pluripotent stem cells: a new revolution for clinical neurology? Lancet Neurol. 10, 383-394 (2011).